Silence Therapeutics
Germany - Berlin
BiotechnologyFocus: RNAi
Silence Therapeutics is a life sciences company focused on RNAi.
Gene Therapy
Open Jobs
0
Pipeline & Clinical Trials
SLN360
HyperlipidemiasClinical Trials (1)
NCT04606602Study to Investigate Safety, Tolerability, PK and PD Response of SLN360 in Subjects With Elevated Lipoprotein(a)
Phase 1Atu027
Advanced Solid TumorsClinical Trials (1)
NCT00938574Study With Atu027 in Patients With Advanced Solid Cancer
Phase 1SLN124 is a GalNAc conjugated double stranded fully modified siRNA. Sodium chloride 0.9% w/v is used as Placebo
Non-transfusion-dependent ThalassemiaClinical Trials (1)
NCT04176653Study in Beta-thalassaemia or Myelodysplastic Syndrome Patients to Investigate the Safety and Tolerability of SLN124
Phase 1SLN124
Healthy VolunteersClinical Trials (1)
NCT04559971A Phase 1 Study to Evaluate the Safety, Tolerability, PK and PD of SLN124 in Healthy Volunteers
Phase 1Phase 1
Clinical Trials (1)
NCT04718844A Study Investigate the Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Response of SLN124 in Adults With Alpha/Beta-thalassaemia and Very Low- and Low-risk Myelodysplastic Syndrome
Phase 1Atu027 & gemcitabine in lead in safety period
Carcinoma, Pancreatic DuctalClinical Trials (1)
NCT01808638Atu027 Plus Gemcitabine in Advanced or Metastatic Pancreatic Cancer (Atu027-I-02)
Phase 1/2SLN124
Polycythemia VeraClinical Trials (1)
NCT05499013Study to Assess SLN124 in Patients With Polycythemia Vera
Phase 1/2SLN360
Cardiovascular DiseasesClinical Trials (1)
NCT05537571Evaluate SLN360 in Participants With Elevated Lipoprotein(a) at High Risk of Atherosclerotic Cardiovascular Disease Events
Phase 2Open Jobs (0)
No open positions listed yet. Check their careers page directly.
Interview Prep Quick Facts
Portfolio: 8 clinical trials